Covid-19's known unknowns: population shared decision making.

BMJ

Younger Lives, London SE1 4YR, UK.

Published: November 2020

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.m4514DOI Listing

Publication Analysis

Top Keywords

covid-19's unknowns
4
unknowns population
4
population shared
4
shared decision
4
decision making
4
covid-19's
1
population
1
shared
1
decision
1
making
1

Similar Publications

COVID-19's Effect on Practice Quality Improvement and Transformation Activities: Practice Survey Results.

Qual Manag Health Care

October 2024

Author Affiliations: Health Unit, Mathematica, Inc., Princeton, NJ (Ms Felt-Lisk, Drs Chandler and Merrill); and Centers for Clinical Standards and Quality, Centers for Medicare & Medicaid Services, Baltimore, MD (Ms Johnson, Drs Everhart and Flemming).

Background And Objectives: The Transforming Clinical Practices Initiative (TCPI) was a 4-year, large-scale, collaborative, peer-based learning initiative for physician practices of all specialties with broad goals to improve the quality of patient care, spend health care dollars more wisely, and assist practices in being ready to succeed under value-based payment (VBP). We investigated whether the COVID-19 pandemic had erased or diminished practice transformation progress made during the TCPI program period, through a follow-up survey of participating practices fielded in October 2021.

Methods: In October 2021 to April 2022, we surveyed a probability sample of 2207 primary care and specialty practices that participated in the TCPI, receiving 610 responses.

View Article and Find Full Text PDF

Objectives: To evaluate the implementation of mifepristone and misoprostol for medical management of early pregnancy loss (EPL) in emergency departments (EDs) by comparing efficacy, complication, and follow-up rates for patients treated in EDs to the Complex Family Planning (CFP) outpatient office.

Study Design: In COVID-19's first wave, we expanded medical management of EPL to our EDs. This retrospective study evaluated 72 patients receiving mifepristone and misoprostol for EPL from April 1, 2020 to March 31, 2021, comparing treatment success, safety outcomes, and follow-up rates by location.

View Article and Find Full Text PDF

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus causing the coronavirus disease of 2019. The disease has caused millions of deaths since the first pandemic at the end of 2019. Immunocompromised individuals are more likely to develop severe infections.

View Article and Find Full Text PDF

A novel virus emerged from Wuhan, China, at the end of 2019 and quickly evolved into a pandemic, significantly impacting various industries, especially healthcare. One critical lesson from COVID-19 is the importance of understanding and predicting underlying comorbidities to better prioritize care and pharmacological therapies. Factors like age, race, and comorbidity history are crucial in determining disease mortality.

View Article and Find Full Text PDF

Objective: There is growing evidence supporting the presence of oral manifestations associated with COVID-19. The study investigates the knowledge of dental undergraduates and recently graduated dentists concerning oral presentations related to COVID-19.

Methods: A cross-sectional descriptive study in Saudi Arabia comprised 305 individuals, including undergraduate dental students, interns, and freshly graduated dentists.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!